The evolution to stool DNA testing for colorectal cancer
- 1 June 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 19 (12) , 1225-1233
- https://doi.org/10.1111/j.1365-2036.2004.02005.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Identifying and managing patients at low risk of bowel cancer in general practiceBMJ, 2003
- The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal CancerNew England Journal of Medicine, 2000
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stoolGastroenterology, 1996
- Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCRInternational Journal of Cancer, 1996
- Mutations of the p53 gene in the stool of patients with resectable colorectal cancerCancer, 1996
- Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.Gut, 1995
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993
- Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal TumorsScience, 1992
- A genetic model for colorectal tumorigenesisCell, 1990